Why the study?
Does intravenous alteplase resolve acute thrombosis in a preterm neonate with prothrombotic risk factors?
Case Report (n=1)
Does intravenous alteplase resolve acute thrombosis in a preterm neonate with prothrombotic risk factors?
Intravenous alteplase (rtPA) can be a safe and effective treatment for acute, life-threatening thrombosis in preterm neonates, even for repeated attacks.
May support alteplase for acute neonatal thrombosis; leaves open need for prospective trials before wider adoption.
UNLABELLED: Herein we report an asphyctic preterm neonate with respiratory distress and prothrombotic risk factors that responded positively to rtPA treatment following 2 attacks of acute thrombosis. CONFLICT OF INTEREST: None declared.
No takes yet. Share an insight, caveat, or question.
Erdinç et al. (2013) conducted a case report in Neonatal thrombosis (n=1). Recombinant tissue plasminogen activator (alteplase) was evaluated on Resolution of thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: